Donanemab exposure‐efficacy relationship in patients with early symptomatic Alzheimer’s disease von Gueorguieva, Ivelina, Chua, Laiyi, Chow, Kay Hoong, Ernest, C Steven, Willis, Brian A., Shcherbinin, Sergey, Sims, John R., Chigutsa, Emmanuel

Volltext

Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient... von Hollebecque, Antoine, Chung, Hyun C., de Miguel, Maria J., Italiano, Antoine, Machiels, Jean-Pascal, Lin, Chia-Chi, Dhani, Neesha C., Peeters, Marc, Moreno, Victor, Su, Wu-Chou, Chow, Kay Hoong, Galvao, Violeta R., Carlsen, Michelle, Yu, Danni, Szpurka, Anna M., Zhao, Yumin, Schmidt, Shelly L., Gandhi, Leena, Xu, Xiaojian, Bang, Yung-Jue

Volltext

Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial von Patnaik, Amita, Yap, Timothy A., Chung, Hyun Cheol, de Miguel, Maria J., Bang, Yung-Jue, Lin, Chia-Chi, Su, Wu-Chou, Italiano, Antoine, Chow, Kay Hoong, Szpurka, Anna M., Yu, Danni, Zhao, Yumin, Carlsen, Michelle, Schmidt, Shelly, Vangerow, Burkhard, Gandhi, Leena, Xu, Xiaojian, Bendell, Johanna

Volltext

An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors von Jotte, Robert M., Von Hoff, Daniel D., Braiteh, Fadi, Becerra, Carlos R., Richards, Donald A., Smith, David A., Garbo, Lawrence, Stephenson, Joe, Conkling, Paul R., Robert-Vizcarrondo, Francisco, Chen, Jian, Turner, P. Kellie, Chow, Kay Hoong, Tai, D. Fritz, Ilaria, Robert

Volltext